219 related articles for article (PubMed ID: 26960148)
81. Invariant chain p41 mediates production of soluble MHC class II molecules.
Shishido T; Kohyama M; Nakai W; Matsumoto M; Miyata H; Suenaga T; Arase H
Biochem Biophys Res Commun; 2019 Jan; 509(1):216-221. PubMed ID: 30587340
[TBL] [Abstract][Full Text] [Related]
82. Anti-cathepsin L monoclonal antibodies that distinguish cathepsin L from cathepsin V.
Kopitar-Jerala N; Bevec T; Barlic-Maganja D; Gubensek F; Turk V
Biol Chem; 2001 May; 382(5):867-70. PubMed ID: 11517943
[TBL] [Abstract][Full Text] [Related]
83. Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.
Chiva C; Barthe P; Codina A; Gairí M; Molina F; Granier C; Pugnière M; Inui T; Nishio H; Nishiuchi Y; Kimura T; Sakakibara S; Albericio F; Giralt E
J Am Chem Soc; 2003 Feb; 125(6):1508-17. PubMed ID: 12568610
[TBL] [Abstract][Full Text] [Related]
84. Dynamic Changes in the Intracellular Association of Selected Rab Small GTPases with MHC Class II and DM during Dendritic Cell Maturation.
Pérez-Montesinos G; López-Ortega O; Piedra-Reyes J; Bonifaz LC; Moreno J
Front Immunol; 2017; 8():340. PubMed ID: 28396666
[TBL] [Abstract][Full Text] [Related]
85. Invariant chain-induced B cell differentiation requires intramembrane proteolytic release of the cytosolic domain.
Matza D; Kerem A; Medvedovsky H; Lantner F; Shachar I
Immunity; 2002 Nov; 17(5):549-60. PubMed ID: 12433362
[TBL] [Abstract][Full Text] [Related]
86. Differential effects of Paclitaxel on dendritic cell function.
John J; Ismail M; Riley C; Askham J; Morgan R; Melcher A; Pandha H
BMC Immunol; 2010 Mar; 11():14. PubMed ID: 20302610
[TBL] [Abstract][Full Text] [Related]
87. Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells.
Burster T; Beck A; Tolosa E; Schnorrer P; Weissert R; Reich M; Kraus M; Kalbacher H; Häring HU; Weber E; Overkleeft H; Driessen C
J Immunol; 2005 Nov; 175(9):5940-9. PubMed ID: 16237087
[TBL] [Abstract][Full Text] [Related]
88. Activity and subcellular distribution of cathepsins in primary human monocytes.
Greiner A; Lautwein A; Overkleeft HS; Weber E; Driessen C
J Leukoc Biol; 2003 Feb; 73(2):235-42. PubMed ID: 12554800
[TBL] [Abstract][Full Text] [Related]
89. Checkpoints and functional stages in DC maturation.
Winzler C; Rovere P; Zimmermann VS; Davoust J; Rescigno M; Citterio S; Ricciardi-Castagnoli P
Adv Exp Med Biol; 1997; 417():59-64. PubMed ID: 9286338
[No Abstract] [Full Text] [Related]
90. Synthetic virus-like particles target dendritic cell lipid rafts for rapid endocytosis primarily but not exclusively by macropinocytosis.
Sharma R; Ghasparian A; Robinson JA; McCullough KC
PLoS One; 2012; 7(8):e43248. PubMed ID: 22905240
[TBL] [Abstract][Full Text] [Related]
91. The immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity.
Sá-Nunes A; Bafica A; Antonelli LR; Choi EY; Francischetti IM; Andersen JF; Shi GP; Chavakis T; Ribeiro JM; Kotsyfakis M
J Immunol; 2009 Jun; 182(12):7422-9. PubMed ID: 19494265
[TBL] [Abstract][Full Text] [Related]
92. GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity.
Phipps-Yonas H; Semik V; Hastings KT
Eur J Immunol; 2013 Jan; 43(1):65-74. PubMed ID: 23012103
[TBL] [Abstract][Full Text] [Related]
93. Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X.
Obermajer N; Svajger U; Bogyo M; Jeras M; Kos J
J Leukoc Biol; 2008 Nov; 84(5):1306-15. PubMed ID: 18701767
[TBL] [Abstract][Full Text] [Related]
94. Cell migration and antigen capture are antagonistic processes coupled by myosin II in dendritic cells.
Chabaud M; Heuzé ML; Bretou M; Vargas P; Maiuri P; Solanes P; Maurin M; Terriac E; Le Berre M; Lankar D; Piolot T; Adelstein RS; Zhang Y; Sixt M; Jacobelli J; Bénichou O; Voituriez R; Piel M; Lennon-Duménil AM
Nat Commun; 2015 Jun; 6():7526. PubMed ID: 26109323
[TBL] [Abstract][Full Text] [Related]
95. Spatial localization of cathepsins: Implications in immune activation and resolution during infections.
Anes E; Pires D; Mandal M; Azevedo-Pereira JM
Front Immunol; 2022; 13():955407. PubMed ID: 35990632
[TBL] [Abstract][Full Text] [Related]
96. An Unusual Two-Domain Thyropin from Tick Saliva: NMR Solution Structure and Highly Selective Inhibition of Cysteine Cathepsins Modulated by Glycosaminoglycans.
Matoušková Z; Orsághová K; Srb P; Pytelková J; Kukačka Z; Buša M; Hajdušek O; Šíma R; Fábry M; Novák P; Horn M; Kopáček P; Mareš M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396918
[TBL] [Abstract][Full Text] [Related]
97. Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression.
Clanchy FIL; Borghese F; Bystrom J; Balog A; Penn H; Taylor PC; Stone TW; Mageed RA; Williams RO
J Autoimmun; 2022 Apr; 128():102810. PubMed ID: 35245865
[TBL] [Abstract][Full Text] [Related]
98. MHC class II vesicles (CIIV) within immature dendritic cells.
Radu E; Regalia T
J Cell Mol Med; 2004; 8(2):266-7. PubMed ID: 15256075
[No Abstract] [Full Text] [Related]
99. Formaldehyde treatment of proteins enhances proteolytic degradation by the endo-lysosomal protease cathepsin S.
Michiels TJM; Meiring HD; Jiskoot W; Kersten GFA; Metz B
Sci Rep; 2020 Jul; 10(1):11535. PubMed ID: 32665578
[TBL] [Abstract][Full Text] [Related]
100. Nordihydroguaiaretic acid blocks secretory and endocytic pathways in human dendritic cells.
Ramoner R; Rieser C; Bartsch G; Thurnher M
J Leukoc Biol; 1998 Dec; 64(6):747-52. PubMed ID: 9850156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
